Se-Hoon Lee

Dr. Se-Hoon Lee is a professor in the Division of Hematology/Oncology at Sungkyunkwan University and is the faculty of Samsung Medical Center. He is a graduate of Seoul National University College of Medicine and completed post-graduate training at Seoul National University College of Medicine. He worked as a visiting scholar at Dana-Farber Cancer Institute and Broad Institute in Boston, which was supervised by Dr. Matthew Meyerson, one of the leader of The Cancer Genome Atlas. Dr. Lee’s area of research and clinical activity have focused on lung cancer and head and neck cancer. He has authored and co-authored over 300 medical articles on clinical and translational oncology and is involved in dozens of clinical trials related to lung cancer or head and neck cancer therapy and diagnostics. His research focuses on finding the association of molecular character and clinical outcomes, and new therapeutic strategy through it. In the era of immunotherapy, his research has moved to exploring genomic and transcriptomic features to predict the clinical response to immunotherapy and discover new therapeutic target for it. His recent publications include the association between DNA global methylation and response to immune checkpoint inhibitors (ICI’s), and the usage of targeted sequencing data for the prediction of response to ICI’s. Dr. Lee serves as a member of the International Association for the Study of Lung Cancer (IASLC), American Society of Clinical Oncology (ASCO) and American Association of Cancer Research (AACR).

Editorial Board
Terms of Appointment: September 2019 - September 2021;  October 2021 - September 2023;  October 2023 - September 2025